SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-24-000360
Filing Date
2024-04-05
Accepted
2024-04-05 11:33:15
Documents
17
Period of Report
2024-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20240320_8k.htm   iXBRL 8-K 32637
2 EXHIBIT 99.1 ex_642530.htm EX-99.1 38574
7 igc_logo1.jpg GRAPHIC 2673
8 igc_logo2.jpg GRAPHIC 5150
  Complete submission text file 0001185185-24-000360.txt   232323

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igc-20240320.xsd EX-101.SCH 3206
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20240320_def.xml EX-101.DEF 10590
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240320_lab.xml EX-101.LAB 19959
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240320_pre.xml EX-101.PRE 10950
20 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20240320_8k_htm.xml XML 2723
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 24825440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)